Halma plc announced three changes to its Executive Board arising from planned succession processes and the evolution of its operational and digital growth strategies. Laura Stoltenberg will succeed Adam Meyers as Sector Chief Executive, Medical & Environmental from 1st October 2019. This Sector Chief Executive role will be a member of the Halma Executive Board. Laura joined Halma as Divisional Chief Executive, Medical & Environmental on January 1, 2019 from Medtronic where she was Vice President and General Manager for MDI Solutions at Medtronic Diabetes. Prior to Medtronic, Laura was Chief Commercial Officer at Exact Sciences Corporation, responsible for sales, marketing, market access and medical affairs. Earlier in her career she held escalating leadership roles at General Electric, including GE Healthcare Lunar, and drove several acquisitions for GE Healthcare. As announced in July 2019, Adam will support Laura in her transition to ensure an orderly handover occurs and he will remain on the Executive Board and the plc Board until July 2020. Ruwan De Soyza has joined Halma as its General Counsel and Company Secretary following the retirement of Carol Chesney. This is a newly created role on Halma's Executive Board, with global responsibility for the Group's legal, compliance, governance and company secretarial affairs. Before joining Halma, Ruwan was the Deputy General Counsel and Head of Public Policy and Government Affairs at Worldpay Inc. Prior to that, Ruwan held positions at Standard Chartered Bank, Accenture and Clifford Chance LLP. Catherine Michel has joined Halma as its first Chief Technology Officer, a newly created role on Halma's Executive Board, with global responsibility for IT and digital architecture. Prior to joining Halma, Catherine was Chief Technology Officer and Chief Strategy Officer at Sigma Systems.